HAEMONETICS CORP — Director's Dealing 2016

Aug 8, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2016-08-04

Reporting Person: Simon, Christopher (President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-04	Common Stock	P	60000	$34.9959	Acquired	105867	Direct

Footnotes

F1: Mr. Simon has 45,867 unvested restricted stock units which are represented here as beneficially owned common stock.